Inventor · disambiguated record
Franciscus Koppenhagen
Also filed as: KOPPENHAGEN FRANCISCUS
20 granted patents·3 pending applications·26 citations·filing 2016–2025
92Inventor score
Files withSCPHARMACEUTICALS INC10GLENMARK SPECIALTY SA8POCKET NALOXONE CORP4LUPIN ATLANTIS HOLDINGS SA1
Top patents by PatentIndex Score
23 records- 0194US12491197B2Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the sameSCPHARMACEUTICALS INC·Filed 2024·Granted Dec 9, 2025·1 cites·24 claims
- 0294US12491193B2Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the sameSCPHARMACEUTICALS INC·Filed 2024·Granted Dec 9, 2025·1 cites·20 claims
- 0394US12491195B2Concentrated liquid pharmaceutical Formulations of furosemide and methods of administering the sameSCPHARMACEUTICALS INC·Filed 2024·Granted Dec 9, 2025·1 cites·22 claims
- 0494US12491194B2Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the sameSCPHARMACEUTICALS INC·Filed 2024·Granted Dec 9, 2025·1 cites·28 claims
- 0594US12491196B2Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the sameSCPHARMACEUTICALS INC·Filed 2024·Granted Dec 9, 2025·1 cites·25 claims
- 0691US11278709B1Drug delivery device and methods for using samePOCKET NALOXONE CORP·Filed 2021·Granted Mar 22, 2022·7 cites·30 claims
- 0790US9987260B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2017·Granted Jun 5, 2018·5 cites·39 claims
- 0889US12017026B2Drug delivery device and methods for using samePOCKET NALOXONE CORP·Filed 2022·Granted Jun 25, 2024·2 cites·15 claims
- 0989US9757365B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2016·Granted Sep 12, 2017·6 cites·35 claims
- 1083US12048709B2Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the sameSCPHARMACEUTICALS INC·Filed 2023·Granted Jul 30, 2024·0 cites·34 claims
- 1183US11559535B2Concentrated liquid pharmaceutical formulations of furosemideSCPHARMACEUTICALS INC·Filed 2022·Granted Jan 24, 2023·0 cites·20 claims
- 1282US11998555B2Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the sameSCPHARMACEUTICALS INC·Filed 2020·Granted Jun 4, 2024·1 cites·20 claims
- 1381US12285581B2Drug delivery device and methods for using samePOCKET NALOXONE CORP·Filed 2024·Granted Apr 29, 2025·0 cites·14 claims
- 1481US11571434B2Concentrated liquid pharmaceutical formulations of furosemideSCPHARMACEUTICALS INC·Filed 2022·Granted Feb 7, 2023·0 cites·20 claims
- 1581US11497755B2Concentrated liquid pharmaceutical formulations of furosemideSCPHARMACEUTICALS INC·Filed 2022·Granted Nov 15, 2022·0 cites·22 claims
- 1670US10632109B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2019·Granted Apr 28, 2020·0 cites·58 claims
- 1770US2025213835A1Drug delivery device and methods for using samePOCKET NALOXONE CORP·Filed 2025·Application pending·0 cites
- 1867US10632108B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2018·Granted Apr 28, 2020·0 cites·20 claims
- 1955US10653683B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2019·Granted May 19, 2020·0 cites·71 claims
- 2051US10617646B2Process for manufacturing dry powder blendsLUPIN ATLANTIS HOLDINGS SA·Filed 2016·Granted Apr 14, 2020·0 cites·31 claims
- 2148US10555903B2Nebulizable compositions of tiotropium and formoterolGLENMARK SPECIALTY SA·Filed 2017·Granted Feb 11, 2020·0 cites·30 claims
- 2238US2018133151A1Nebulized tiotropiumGLENMARK SPECIALTY SA·Filed 2017·Application pending·0 cites
- 2335US2016310410A1Pharmaceutical compositions comprising arformoterol and glycopyrroniumGLENMARK SPECIALTY SA·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →